|
Uniphar PLC - Dublin-based healthcare services company - Says achieved 21% adjusted earnings per share growth in 2025, compared to 20.50 euro cents in 2024 and ahead of its own expectations. Further, organic gross profit growth was around 9% in 2025. For 2024, it had reported gross profit of €427.6 million. Uniphar says it continues to maintain a ‘strong’ liquidity position. It adds it is well positioned to deliver organic gross profit growth across all divisions. Chief Executive Officer Ger Rabbette says: ‘2025 was another great year for Uniphar, with all our divisions contributing to our fastest rate of organic gross profit growth since initial public offering. This underscores the positive impact that our strategy is having on our ability to scale organically. We have now delivered an excellent six-year earnings per share compound annual growth rate of 16%. We remain confident of reaching our €200 million earnings before interest, tax, depreciation and amortisation target by 2028, with at least 80% of our growth being organic.’ The firm’s 2024 Ebitda was €123.5 million. Uniphar expects to publish 2025 results on February 24. Current stock price: 328.00 pence each, up 5.5% on Tuesday morning in London 12-month change: up 84% Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
